| |
|
Form Serial Number: |
CS20260804E00259 |
| 1.
Date of relevant event: |
30/07/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
02171 |
| 4.
Name of listed corporation: |
CARsgen Therapeutics Holdings Ltd. - B |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
594,229,547 |
| 7.
Name of substantial shareholder: |
Quanzhou Dingwo Chuangfeng Investment Center (Limited Partnership) 泉州市鼎沃創豐投資中心(有限合夥) |
| 8.
Registered office: |
泉州市豐澤區浦西萬達廣場商業綜合體1號建築（甲級寫字樓1B）B2807 |
| 9.
Principal place of business in Hong Kong: |
N/A |
| 15.
Exchange on which listed: |
|
| 16.
Name of listed parent and exchange on which parent is listed: |
|
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1213 | The percentage level of your interest in the shares has reduced because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
|
7,228,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 225,848,730 | 37.55 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 218,620,730 | 36.79 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| |
| 2401 | A concert party to an agreement to buy shares described in s.317(1)(a) |
| |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| | | | | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| Chen Haiou | Addresses of individuals are not displayed. | 201,497,286 |
| Li Zonghai | Addresses of individuals are not displayed. | 198,239,536 |
| CART Biotech Limited | Addresses of individuals are not displayed. | 198,139,536 |
| Guo Bingsen | Addresses of individuals are not displayed. | 198,139,536 |
| Redelle Holding Limited | Addresses of individuals are not displayed. | 198,139,536 |
| Wang Huamao | Addresses of individuals are not displayed. | 198,239,536 |
| He Xi Holdings Limited | Addresses of individuals are not displayed. | 198,139,536 |
| Guo Huaqing | Addresses of individuals are not displayed. | 200,618,536 |
| Candock Holdings Limited | Addresses of individuals are not displayed. | 198,139,536 |
| Accure Biotech Limited | Addresses of individuals are not displayed. | 198,139,536 |
| YIJIE Biotech Holding Limited | Addresses of individuals are not displayed. | 198,139,536 |
| Yang Xuehong | Addresses of individuals are not displayed. | 8,888,888 |
| Yeed Holdings Limited | Addresses of individuals are not displayed. | 8,888,888 |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | 213,065,174 |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
The percentage level of Quanzhou Dingwo Chuangfeng Investment Center (Limited Partnership) 's interests in the shares of CARsgen Therapeutics Holdings Ltd. (the "Company") has decreased upon the cancellation of 7,228,000 treasury shares of the Company on July 30, 2026.
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
1
A0000000000002158798.pdf
|
|
Date of filing this Form 2: |
04/08/2026
(dd/mm/yyyy)
|
|
|
|
|